You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Matched Related Donor Transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

Not yet recruiting
  • SIOD With CKD Stage 3 Through 5
  • +3 more
  • Cyclophosphamide 1200 mg/Kg
  • +8 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Aug 17, 2022

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

Recruiting
  • Leukemia
  • +2 more
  • Alpha Beta T cell depletion
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 27, 2021

Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)

Completed
  • Multiple Myeloma
  • Amyloidosis
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 24, 2021

Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
May 25, 2021

Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

Recruiting
  • Sickle Cell Disease
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jul 31, 2022

DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

Recruiting
  • DOCK8 Deficiency
  • Reduced-intensity hematopoietic stem cell
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

Completed
Has Results
  • Acute Myeloid Leukemia
  • Advanced Myelodysplastic Syndromes
  • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 27, 2021

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia

Recruiting
  • Acquired Aplastic Anemia
  • +2 more
  • CliniMACs
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 1, 2022

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

High Risk Hematologic Malignancies Trial in Salt Lake City (stem cell transplant, Stem cell transplant)

Terminated
  • High Risk Hematologic Malignancies
  • stem cell transplant
  • Stem cell transplant
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 10, 2020

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with

Recruiting
  • Bone Marrow Failure Syndromes
  • MRD-BMT with Fludarabine-based RIC for Acquired AA
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
May 6, 2022

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

Immune Tolerance Trial in Palo Alto, Madison (Immune tolerance after kidney transplant, Donor blood stem cells and T cells)

Recruiting
  • Immune Tolerance
  • Immune tolerance after kidney transplant
  • Donor blood stem cells and T cells
  • Palo Alto, California
  • +1 more
Jul 15, 2020